The Long Run with Luke Timmerman
Podcast autorstwa Timmerman Report
173 Odcinki
-
Ep175: Andy Scharenberg on in vivo CAR-T cell therapies
Opublikowany: 16.03.2025 -
Ep174: Najat Khan on the TechBio Movement
Opublikowany: 3.03.2025 -
Ep173: Robert Blum on Building a Fully Integrated Biopharma For Muscle Disorders
Opublikowany: 11.02.2025 -
Ep172: Mostafa Ronaghi on Studying Live Cells at Scale
Opublikowany: 27.01.2025 -
Ep171: Ram Aiyar on RNA Editing Medicines
Opublikowany: 13.01.2025 -
Ep170: David Schenkein on Investing in the Future of Biotech
Opublikowany: 2.01.2025 -
Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines
Opublikowany: 11.12.2024 -
Ep168: Jonathan Bricker on How to Quit Smoking & Prevent Cancer
Opublikowany: 25.11.2024 -
Ep167: Leslie Williams on transfer RNA therapies
Opublikowany: 6.11.2024 -
Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity
Opublikowany: 15.10.2024 -
Ep165: Zach Hornby on Tackling Cancer Drug Resistance
Opublikowany: 26.09.2024 -
Ep164: Ted Love and Alan Anderson on Raising the Bar for Sickle Cell Disease Patients
Opublikowany: 5.09.2024 -
Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases
Opublikowany: 14.08.2024 -
Ep162: Sean McClain on AI for Biologic Drug Discovery
Opublikowany: 16.07.2024 -
Ep161: Jeff Stein on a Long-Lasting Flu Drug
Opublikowany: 1.07.2024 -
Ep160: Abe Ceesay on Precision Neuroscience
Opublikowany: 17.06.2024 -
Ep159: Jimi Olaghere on Being Functionally Cured of Sickle Cell Disease
Opublikowany: 3.06.2024 -
Ep158: David Younger and Randolph Lopez on SynBio & AI for Discovery
Opublikowany: 20.05.2024 -
Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery
Opublikowany: 1.05.2024 -
Ep156: David Liu on New Tools and Techniques for Biology
Opublikowany: 16.04.2024
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
